There’s some good news being dispatched from the medical weed front today. After almost four decades, the National Institutes of Health now agrees with Peter Tosh and added an important update to their site regarding pot.
Turns out, it is therapeutic after all. Here’s their new position:
Cannabinoids may cause antitumor effects by various mechanisms, including induction of cell death, inhibition of cell growth, and inhibition of tumor angiogenesis and metastasis. Cannabinoids appear to kill tumor cells but do not affect their nontransformed counterparts and may even protect them from cell death.
…The potential benefits of medicinal cannabis for people living with cancer include antiemetic effects, appetite stimulation, pain relief, and improved sleep. In the practice of integrative oncology, the health care provider may recommend medicinal cannabis not only for symptom management but also for its possible direct antitumor effect.
So what if it only took them 36 years, it’s better late than never right? Wait till the DEA hears about this, as it runs contrary to their official position. In related news medical cannabis is already a billion-dollar industry and is only expected to grow, pun VERY intended!